88000923 - NEO STIM

Information

  • Trademark
  • 88000923
  • Serial Number
    88000923
  • Registration Number
    5854518
  • Filing Date
    June 14, 2018
    6 years ago
  • Registration Date
    September 10, 2019
    5 years ago
  • Transaction Date
    September 10, 2024
    4 days ago
  • Status Date
    September 10, 2019
    5 years ago
  • Published for Opposition Date
    June 25, 2019
    5 years ago
  • Location Date
    June 03, 2022
    2 years ago
  • First Use Anywhere Date
    March 02, 2018
    6 years ago
  • First Use In Commerce Date
    March 02, 2018
    6 years ago
  • Status Code
    700
  • Current Location
    TMO LAW OFFICE 115
    Employee Name
    HUNT, LEE
  • Attorney Docket Number
    3814.0350001
    Attorney Name
    Monica Riva Talley
    Law Office Assigned Location Code
    M60
  • Owners
Mark Drawing Code
3
Mark Identification
NEO STIM
Case File Statements
  • DM0000: The mark consists of the word "NEO", with the letter "O" pictured with a central filled-in circle design, four lines of varying lengths radiating outward, and each line ending in a smaller circle, set on top of the word "STIM".
  • A00001: Issue New Certificate to: BioNTech US Inc. (Delaware corporation) 40 Erie Street, Suite 110, Cambridge MA 02139.
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0441: Medical and pharmaceutical consultation; and providing information relating to therapeutic properties of pharmaceuticals
  • GS0421: Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platform for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer and oncological conditions; and consulting services for others in the field of design, planning, and implementation of clinical trials
Case File Event Statements
  • 6/20/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/18/2018 - 6 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 10/1/2018 - 5 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/9/2018 - 5 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/9/2019 - 5 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/19/2019 - 5 years ago
    12 - ASSIGNED TO LIE Type: ALIE
  • 6/21/2018 - 6 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 10/9/2018 - 5 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/9/2018 - 5 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/9/2019 - 5 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/10/2019 - 5 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/6/2019 - 5 years ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/5/2019 - 5 years ago
    13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/25/2019 - 5 years ago
    14 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/25/2019 - 5 years ago
    15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/10/2019 - 5 years ago
    16 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/2/2022 - 2 years ago
    18 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 1/6/2022 - 2 years ago
    17 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R
  • 6/3/2022 - 2 years ago
    19 - NEW CERTIFICATE UNDER SECTION 7 - PROCESSED Type: C.7C
  • 9/10/2024 - 4 days ago
    20 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1